Contact SCGE




SCGE Consortium Home   |  About SCGE Toolkit   |  Contact Us   |  Citing the Toolkit   |  License  
!
Scheduled Maintenance Notice

The site will be undergoing scheduled maintenance on Wednesday 22nd July 2026 from 12:30AM to 1:30PM Central Time (CT). During this time, the site may be temporarily unavailable. We apologize for any inconvenience.

ExperimentGene editing in vitro by various peptide variants delivering Cas12a in NK cells.
Experiment ConditionS10
Assay Description: Calculated editing efficiency by T7E1 digestion.
Tissue Measured:
Measurement Type:Editing Efficiency
Record ID15000000531

EditorAsCas12a (Feldan Therapeutics)
Delivery SystemS10
Delivery System SubtypeAmphiphilic peptide
GuideNKG2A
Vector

Model SpeciesHuman
Model NameNK

Application Method
Application Site
Dosage1.33uM Cas12a/2.0uM gRNA/7.5uM Shuttle Peptide
Injection Frequency
Injection Rate
Injection Volume
Days post injection48 hours
Editor Formatribonucleoprotein (RNP)
Antidote Id
Antidote Description

Measured Values
Samples Size: 3
 
Replicate Result (Editing Efficiency)
Measurement Units: % indel
Mean 24.99 
1 23.95680 
2 24.02615 
3 26.98109 
  

Publication Title
Engineered amphiphilic peptides enable delivery of proteins and CRISPR-associated nucleases to airway epithelia. NCBI